AVS Pulse, Inc
  • Technology
    • Pulse IVL™
    • Mechanism of Action
  • Clinical Evidence
    • Peripheral Clinical Evidence
  • About AVS
    • Company Overview
    • Leadership Team
    • Careers
  • News & Press Releases
Contact Us
AVS Pulse, Inc
  • Technology
    • Pulse IVL™
    • Mechanism of Action
  • Clinical Evidence
    • Peripheral Clinical Evidence
  • About AVS
    • Company Overview
    • Leadership Team
    • Careers
  • News & Press Releases
Contact Us
Home > News & Releases > Pulse IVL with Angie Volk & Sean Gilligan of AVS

Pulse IVL with Angie Volk & Sean Gilligan of AVS

Angie Volk, VP of Business Development at AVS, and Sean Gilligan, COO at AVS, recently sat down with Kyle Kruse and Richard Meiklejohn on The Medtech Impact Podcast to discuss AVS’ mission and how the Pulse IVL System is designed to safely and effectively treat calcified arterial disease. Listen to the episode

Read Full Story Return to News

451 D Street
Suite 802

Boston, MA 02210

  • Technology
    • Pulse IVL™
    • Mechanism of Action
  • Clinical Evidence
    • Peripheral Evidence
  • About
    • Company Overview
    • Leadership Team
    • Careers
    • News & Press Releases
    • Contact

NOTE: AVS Pulse is an investigational device and is not approved for commercial use in any geography.

Copyright © 2025. AVS Pulse, Inc. All rights reserved.